Rossi Gian Paolo, Cesari Maurizio, Zanchetta Mario, Colonna Stefania, Maiolino Giuseppe, Pedon Luigi, Cavallin Martina, Maiolino Pietro, Pessina Achille C
Department of Clinical and Experimental Medicine, Clinica Medica 4 University Hospital, University of Padua, via Giustiniani 2, 35126 Padua, Italy.
J Am Coll Cardiol. 2003 Mar 19;41(6):930-7. doi: 10.1016/s0735-1097(02)03012-7.
We investigated the association of polymorphisms in the promoter region and exon 7 endothelial nitric oxide synthase (eNOS) gene with coronary artery disease (CAD).
Endothelial dysfunction foretells cardiovascular events and can be genetically determined.
We genotyped for the promoter (T(-786)C) and exon 7 (Glu298Asp, G(894)T) polymorphisms in 1,225 subjects; 1,106 were consecutive patients undergoing coronary angiography and 119 control subjects without any cardiovascular risk factors. Genotyping was performed with melting curve analysis of polymerase chain reaction products from allele-specific acceptor and donor probes that were 5'- and 3'-end labeled with LCRed640 and fluorescein, respectively; CAD was assessed by quantitative coronary angiography. We performed multiple logistic regression analysis for the effect of the T(-786)C, the missense Glu298Asp variant, and other coronary risk factors on two- and three-vessel CAD.
The overall genotype distribution of T(-786)C (CC = 17.7%, CT = 40.4%, and TT = 41.9%) and Glu298Asp (GG = 43.3%, GT = 37.0%, and TT = 19.7%) was consistent with the Hardy-Weinberg equilibrium. The regression analysis showed that the T(-786)C, but not the missense Glu298Asp variant, significantly predicted CAD, independent of other risk factors. Compared with TT homozygous, subjects carrying the C allele had a significant (p = 0.002) increase in the odds ratio of harboring two- or three-vessel CAD of 1.672 (95% confidence interval, 1.062 to 2.527). A subgroup analysis confirmed this effect of the T(-786)C polymorphism in men (p = 0.007), cigarette smokers (p = 0.001), subjects older than 60 years of age (p = 0.007), with hypercholesterolemia (p = 0.011), low high-density lipoprotein cholesterol (p = 0.006), and overweight or with obesity (p = 0.041).
The C allele at the T(-786)C endothelial nitric oxide synthase polymorphism is associated with a higher risk of multivessel CAD in Caucasians.
我们研究了内皮型一氧化氮合酶(eNOS)基因启动子区域和第7外显子的多态性与冠状动脉疾病(CAD)之间的关联。
内皮功能障碍预示着心血管事件,并且可能由基因决定。
我们对1225名受试者的启动子(T(-786)C)和第7外显子(Glu298Asp,G(894)T)多态性进行了基因分型;其中1106名是连续接受冠状动脉造影的患者,119名是没有任何心血管危险因素的对照受试者。基因分型采用聚合酶链反应产物的熔解曲线分析,等位基因特异性受体和供体探针分别在5'端和3'端用LCRed640和荧光素标记;通过定量冠状动脉造影评估CAD。我们对T(-786)C、错义Glu298Asp变异以及其他冠状动脉危险因素对双支和三支血管CAD的影响进行了多因素逻辑回归分析。
T(-786)C(CC = 17.7%,CT = 40.4%,TT = 41.9%)和Glu298Asp(GG = 43.3%,GT = 37.0%,TT = 19.7%)的总体基因型分布符合哈迪-温伯格平衡。回归分析表明,T(-786)C而非错义Glu298Asp变异可独立于其他危险因素显著预测CAD。与TT纯合子相比,携带C等位基因的受试者患双支或三支血管CAD的比值比显著增加(p = 0.002),为1.672(95%置信区间,1.062至2.527)。亚组分析证实了T(-786)C多态性在男性(p = 0.007)、吸烟者(p = 0.001)、60岁以上受试者(p = 0.007)、高胆固醇血症患者(p = 0.011)、低高密度脂蛋白胆固醇患者(p = 0.006)以及超重或肥胖患者(p = 0.041)中的这种作用。
在白种人中,T(-786)C内皮型一氧化氮合酶多态性位点的C等位基因与多支血管CAD的较高风险相关。